Evidence map›Paper›PMID 37122480›Full record

ArticleClinical epidemiology2023

Beneficial Effect of

Heng-Ming Ye, Min-Jie Lu, Qiang Liu, Ying Lin, Lu-Ying Tang, Ze-Fang Ren

Open access · goldAbstract read
In one paragraph

Article in Clinical epidemiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Cohort profile: Guangzhou breast cancer study (GBCS).European journal of epidemiology · 2024
    Article
  4. Parasites revive hope for cancer therapy.European journal of medical research · 2024
    Review
  5. Article
  6. A novel enemy of cancer: recent investigations into protozoan anti-tumor properties.Frontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Heng-Ming YeThe School of Public Health, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China.ORCID 0000-0003-3303-3792
Min-Jie LuThe School of Public Health, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China.ORCID 0000-0001-9165-9916
Qiang LiuSun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, People's Republic of China.
Ying LinThe First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China.
Lu-Ying TangThe Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, People's Republic of China.
Ze-Fang RenThe School of Public Health, Sun Yat-sen University, Guangzhou, 510080, People's Republic of China.ORCID 0000-0002-7785-4704
Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Animal experiments have shown the anticancer activity of Methods: A total of 1121 breast cancer patients were recruited between 2008 and 2018 and followed up until December 31, 2021. Anti- Results: According to the cutoff value of optical density (OD=0.111), 900 (80.29%) and 221 (19.71%) patients were divided into two groups: low or high anti- Conclusion: Anti-

Indexed as

breast cancercytokinesprognosisToxoplasma gondii

Identifiers

PMID37122480
PMCPMC10145453
OpenAlexW4366831528

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.